Grace Therapeutics, Inc. beat EPS estimates 100% of the time across 1 reported quarters (1 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q12027 FY2027 | — | $-0.91 | — | Miss |
| Q42026 FY2026 | $-0.24 | $-0.07 | +70.8% | Beat |
| Q32026 FY2026 | $-0.09 | — | — | Miss |
Back to GRCE overview · GRCE holders · GRCE KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.